{"id":4193,"date":"2026-07-22T02:29:36","date_gmt":"2026-07-22T02:29:36","guid":{"rendered":"https:\/\/silvybrand.com\/?p=4193"},"modified":"2026-07-22T02:29:36","modified_gmt":"2026-07-22T02:29:36","slug":"fda-peptide-decision-telehealth-companies-cashing-in","status":"publish","type":"post","link":"https:\/\/silvybrand.com\/?p=4193","title":{"rendered":"The Great Peptide Cash Grab Has Begun"},"content":{"rendered":"<p><br \/>\n<\/p>\n<div>\n<p><span class=\"lead-in-text-callout\">Has anyone tried<\/span> to sell you <a href=\"https:\/\/www.wired.com\/story\/telehealth-middlemen-turnkey-healthcare-providers-glp1\/\" class=\"text link\">peptides<\/a> yet? If not, they probably will soon. Once a niche interest among bodybuilders and biohackers, peptides are an increasingly popular class of substance hyped by both fringe influencers and the current US secretary of Health and Human Services.<\/p>\n<p class=\"paywall\">Earlier this year, Robert F. Kennedy Jr. told the podcaster Joe Rogan that the government intended to loosen restrictions on peptide production. This week, it could finally happen: On July 23 and 24, the Food and Drug Administration will discuss whether to reclassify a group of peptides so that pharmacies can legally make custom mixes, a process known as compounding. The move would reverse a decision made in 2023 by the Biden administration, which barred certain peptides from being compounded.<\/p>\n<p class=\"paywall\">Although career scientists at the agency have <a href=\"https:\/\/www.fda.gov\/advisory-committees\/advisory-committee-calendar\/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026#event-materials\" class=\"text link\">recommended against it<\/a>, many industry insiders tell WIRED they believe the FDA will approve reclassification anyway, since the committee put together to do the assessment <a href=\"https:\/\/www.pbs.org\/newshour\/health\/fda-panel-on-peptides-will-include-experts-who-promote-the-unproven-chemicals-favored-by-rfk-jr\" class=\"text link\">includes peptide boosters.<\/a> Some players in the telehealth world are already operating under the assumption that the floodgates will soon open. \u201cWe\u2019re getting everything ready to go,\u201d says Myra Ahmad, the chief executive of the telehealth platform Mochi Health, which originally focused on <a href=\"https:\/\/www.wired.com\/tag\/glp-1\/\" class=\"text link\">GLP-1<\/a> medications. \u201cWe have pharmacies that have done all their safety testing stuff; they\u2019re putting pricing together.\u201d<\/p>\n<p class=\"paywall\">Some of the largest telehealth companies have looked forward to this moment for over a year. Virtual health care juggernaut Hims &amp; Hers Health purchased a peptide manufacturing facility in February 2025 and is developing clinical protocols for peptides, according to its chief medical officer, Anant Vinjamoori, who is slated to testify at the FDA hearing. Joshua Fritzler, president of the compounding pharmacy Olympia Pharmaceuticals, says the company has been preparing in advance of the anticipated changes, \u201cspending a lot of money to create these formulas\u201d to be ready if the FDA gives the green light.<\/p>\n<p class=\"paywall\">\u201cThere\u2019s an understanding in the industry that something big is happening,\u201d he says.<\/p>\n<p class=\"paywall\">The GLP-1 boom warmed people up to the idea of injecting medications at home and proved to be a cash cow for pharmacies and virtual clinics. Now, though, many of these companies are eager to expand their horizons. Cole Thomas, the director of sales and operations at the pharmacy marketing and technology platform RxConnexion, says that some of the company\u2019s compounding pharmacy clients are testing peptides that are likely to be popular. One such variety, <a data-offer-url=\"https:\/\/undark.org\/2026\/05\/29\/stress-test-bpc-157-history\/\" class=\"external-link text link\" data-event-click=\"{&quot;element&quot;:&quot;ExternalLink&quot;,&quot;outgoingURL&quot;:&quot;https:\/\/undark.org\/2026\/05\/29\/stress-test-bpc-157-history\/&quot;}\" href=\"https:\/\/undark.org\/2026\/05\/29\/stress-test-bpc-157-history\/\" rel=\"nofollow noopener\" target=\"_blank\">BPC-157<\/a>, is touted as a healing compound and is one-half of the combination known as the \u201cWolverine stack.\u201d (BPC stands for \u201cbody protection compound.\u201d)<\/p>\n<p class=\"paywall\">Cameron Bravo, a research scientist at the biotech firm Sapho Bio, says his company has been approached about testing a variety of peptides already, too. (Mochi Health is a client.) Sapho Bio runs tests to \u201cvalidate\u201d formulas that clients bring, ensuring the mixtures are uncontaminated and properly sealed. So far, it has tested BPC-157 as well as more obscure offerings like MOTS-c, which is hyped as \u201cexercise in a vial\u201d by evangelists. Some of the pharmacies the company works with are testing multiple products, at significant cost. \u201cThey&#8217;re probably investing something like $100,000 into these before they&#8217;re even fully out yet,\u201d he says.<\/p>\n<p class=\"paywall\">Even if this week\u2019s meeting goes exactly how peptide boosters want it to go, with the committee approving all of the substances up for discussion, that won\u2019t lead to an immediate green light for sellers. The next step involves a review period, during which the FDA will propose rules and the public will be able to comment. \u201cIt\u2019s a long-winded process,\u201d says Gerard Olson, who was recently the director of research at LegitScript, a company that provides certifications for telehealth providers and pharmacies.<\/p>\n<\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.wired.com\/story\/fda-peptide-decision-telehealth-companies-cashing-in\/\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Has anyone tried to sell you peptides yet? If not, they probably will soon. Once a niche interest among bodybuilders and biohackers, peptides are an increasingly popular class of substance hyped by both fringe influencers and the current US secretary of Health and Human Services. Earlier this year, Robert F. Kennedy Jr. told the podcaster [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":4194,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[9],"tags":[523,868,141,1020,179],"class_list":["post-4193","post","type-post","status-publish","format-standard","has-post-thumbnail","category-gadgets","tag-fda","tag-glp-1","tag-health","tag-pharmaceutical-industry","tag-regulation"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>The Great Peptide Cash Grab Has Begun - Silvybrand Lifestyle Blog<\/title>\n<meta name=\"description\" content=\"The FDA could decide whether to loosen rules around peptide production this week. Some telehealth players are already seeing dollar signs.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/silvybrand.com\/?p=4193\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Great Peptide Cash Grab Has Begun - Silvybrand Lifestyle Blog\" \/>\n<meta property=\"og:description\" content=\"The FDA could decide whether to loosen rules around peptide production this week. Some telehealth players are already seeing dollar signs.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/silvybrand.com\/?p=4193\" \/>\n<meta property=\"og:site_name\" content=\"Silvybrand Lifestyle Blog\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-22T02:29:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/silvybrand.com\/wp-content\/uploads\/2026\/07\/Business_TheGreatPeptideLandGrabHasBegun_v1_.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"670\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"SILVYBRAND\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"SILVYBRAND\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/silvybrand.com\\\/?p=4193#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/silvybrand.com\\\/?p=4193\"},\"author\":{\"name\":\"SILVYBRAND\",\"@id\":\"https:\\\/\\\/silvybrand.com\\\/#\\\/schema\\\/person\\\/8bdc6818a5b6ef5b9745e468818e37f3\"},\"headline\":\"The Great Peptide Cash Grab Has Begun\",\"datePublished\":\"2026-07-22T02:29:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/silvybrand.com\\\/?p=4193\"},\"wordCount\":626,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/silvybrand.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/silvybrand.com\\\/?p=4193#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/silvybrand.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Business_TheGreatPeptideLandGrabHasBegun_v1_.jpg\",\"keywords\":[\"fda\",\"glp-1\",\"health\",\"pharmaceutical industry\",\"regulation\"],\"articleSection\":[\"Gadgets\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/silvybrand.com\\\/?p=4193#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/silvybrand.com\\\/?p=4193\",\"url\":\"https:\\\/\\\/silvybrand.com\\\/?p=4193\",\"name\":\"The Great Peptide Cash Grab Has Begun - Silvybrand Lifestyle Blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/silvybrand.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/silvybrand.com\\\/?p=4193#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/silvybrand.com\\\/?p=4193#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/silvybrand.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Business_TheGreatPeptideLandGrabHasBegun_v1_.jpg\",\"datePublished\":\"2026-07-22T02:29:36+00:00\",\"description\":\"The FDA could decide whether to loosen rules around peptide production this week. Some telehealth players are already seeing dollar signs.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/silvybrand.com\\\/?p=4193#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/silvybrand.com\\\/?p=4193\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/silvybrand.com\\\/?p=4193#primaryimage\",\"url\":\"https:\\\/\\\/silvybrand.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Business_TheGreatPeptideLandGrabHasBegun_v1_.jpg\",\"contentUrl\":\"https:\\\/\\\/silvybrand.com\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Business_TheGreatPeptideLandGrabHasBegun_v1_.jpg\",\"width\":1280,\"height\":670},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/silvybrand.com\\\/?p=4193#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/silvybrand.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Great Peptide Cash Grab Has Begun\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/silvybrand.com\\\/#website\",\"url\":\"https:\\\/\\\/silvybrand.com\\\/\",\"name\":\"Silvybrand Lifestyle Blog\",\"description\":\"Your daily dose of lifestyle, fashion, travel, beauty, and inspiration \u2014 living boldly, stylishly, and confidently.\",\"publisher\":{\"@id\":\"https:\\\/\\\/silvybrand.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/silvybrand.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/silvybrand.com\\\/#organization\",\"name\":\"Silvybrand Lifestyle Blog\",\"url\":\"https:\\\/\\\/silvybrand.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/silvybrand.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/silvybrand.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/SILVYBRAND-LOGO.jpg\",\"contentUrl\":\"https:\\\/\\\/silvybrand.com\\\/wp-content\\\/uploads\\\/2026\\\/05\\\/SILVYBRAND-LOGO.jpg\",\"width\":1115,\"height\":522,\"caption\":\"Silvybrand Lifestyle Blog\"},\"image\":{\"@id\":\"https:\\\/\\\/silvybrand.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/silvybrand.com\\\/#\\\/schema\\\/person\\\/8bdc6818a5b6ef5b9745e468818e37f3\",\"name\":\"SILVYBRAND\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e7db54afd7d090e59e1a481fd3e6812d467eb2a3b81e7a3092023acfc59a496b?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e7db54afd7d090e59e1a481fd3e6812d467eb2a3b81e7a3092023acfc59a496b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/e7db54afd7d090e59e1a481fd3e6812d467eb2a3b81e7a3092023acfc59a496b?s=96&d=mm&r=g\",\"caption\":\"SILVYBRAND\"},\"sameAs\":[\"https:\\\/\\\/silvybrand.com\"],\"url\":\"https:\\\/\\\/silvybrand.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Great Peptide Cash Grab Has Begun - Silvybrand Lifestyle Blog","description":"The FDA could decide whether to loosen rules around peptide production this week. Some telehealth players are already seeing dollar signs.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/silvybrand.com\/?p=4193","og_locale":"en_US","og_type":"article","og_title":"The Great Peptide Cash Grab Has Begun - Silvybrand Lifestyle Blog","og_description":"The FDA could decide whether to loosen rules around peptide production this week. Some telehealth players are already seeing dollar signs.","og_url":"https:\/\/silvybrand.com\/?p=4193","og_site_name":"Silvybrand Lifestyle Blog","article_published_time":"2026-07-22T02:29:36+00:00","og_image":[{"width":1280,"height":670,"url":"https:\/\/silvybrand.com\/wp-content\/uploads\/2026\/07\/Business_TheGreatPeptideLandGrabHasBegun_v1_.jpg","type":"image\/jpeg"}],"author":"SILVYBRAND","twitter_card":"summary_large_image","twitter_misc":{"Written by":"SILVYBRAND","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/silvybrand.com\/?p=4193#article","isPartOf":{"@id":"https:\/\/silvybrand.com\/?p=4193"},"author":{"name":"SILVYBRAND","@id":"https:\/\/silvybrand.com\/#\/schema\/person\/8bdc6818a5b6ef5b9745e468818e37f3"},"headline":"The Great Peptide Cash Grab Has Begun","datePublished":"2026-07-22T02:29:36+00:00","mainEntityOfPage":{"@id":"https:\/\/silvybrand.com\/?p=4193"},"wordCount":626,"commentCount":0,"publisher":{"@id":"https:\/\/silvybrand.com\/#organization"},"image":{"@id":"https:\/\/silvybrand.com\/?p=4193#primaryimage"},"thumbnailUrl":"https:\/\/silvybrand.com\/wp-content\/uploads\/2026\/07\/Business_TheGreatPeptideLandGrabHasBegun_v1_.jpg","keywords":["fda","glp-1","health","pharmaceutical industry","regulation"],"articleSection":["Gadgets"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/silvybrand.com\/?p=4193#respond"]}]},{"@type":"WebPage","@id":"https:\/\/silvybrand.com\/?p=4193","url":"https:\/\/silvybrand.com\/?p=4193","name":"The Great Peptide Cash Grab Has Begun - Silvybrand Lifestyle Blog","isPartOf":{"@id":"https:\/\/silvybrand.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/silvybrand.com\/?p=4193#primaryimage"},"image":{"@id":"https:\/\/silvybrand.com\/?p=4193#primaryimage"},"thumbnailUrl":"https:\/\/silvybrand.com\/wp-content\/uploads\/2026\/07\/Business_TheGreatPeptideLandGrabHasBegun_v1_.jpg","datePublished":"2026-07-22T02:29:36+00:00","description":"The FDA could decide whether to loosen rules around peptide production this week. Some telehealth players are already seeing dollar signs.","breadcrumb":{"@id":"https:\/\/silvybrand.com\/?p=4193#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/silvybrand.com\/?p=4193"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/silvybrand.com\/?p=4193#primaryimage","url":"https:\/\/silvybrand.com\/wp-content\/uploads\/2026\/07\/Business_TheGreatPeptideLandGrabHasBegun_v1_.jpg","contentUrl":"https:\/\/silvybrand.com\/wp-content\/uploads\/2026\/07\/Business_TheGreatPeptideLandGrabHasBegun_v1_.jpg","width":1280,"height":670},{"@type":"BreadcrumbList","@id":"https:\/\/silvybrand.com\/?p=4193#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/silvybrand.com\/"},{"@type":"ListItem","position":2,"name":"The Great Peptide Cash Grab Has Begun"}]},{"@type":"WebSite","@id":"https:\/\/silvybrand.com\/#website","url":"https:\/\/silvybrand.com\/","name":"Silvybrand Lifestyle Blog","description":"Your daily dose of lifestyle, fashion, travel, beauty, and inspiration \u2014 living boldly, stylishly, and confidently.","publisher":{"@id":"https:\/\/silvybrand.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/silvybrand.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/silvybrand.com\/#organization","name":"Silvybrand Lifestyle Blog","url":"https:\/\/silvybrand.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/silvybrand.com\/#\/schema\/logo\/image\/","url":"https:\/\/silvybrand.com\/wp-content\/uploads\/2026\/05\/SILVYBRAND-LOGO.jpg","contentUrl":"https:\/\/silvybrand.com\/wp-content\/uploads\/2026\/05\/SILVYBRAND-LOGO.jpg","width":1115,"height":522,"caption":"Silvybrand Lifestyle Blog"},"image":{"@id":"https:\/\/silvybrand.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/silvybrand.com\/#\/schema\/person\/8bdc6818a5b6ef5b9745e468818e37f3","name":"SILVYBRAND","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e7db54afd7d090e59e1a481fd3e6812d467eb2a3b81e7a3092023acfc59a496b?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e7db54afd7d090e59e1a481fd3e6812d467eb2a3b81e7a3092023acfc59a496b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e7db54afd7d090e59e1a481fd3e6812d467eb2a3b81e7a3092023acfc59a496b?s=96&d=mm&r=g","caption":"SILVYBRAND"},"sameAs":["https:\/\/silvybrand.com"],"url":"https:\/\/silvybrand.com\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/silvybrand.com\/index.php?rest_route=\/wp\/v2\/posts\/4193","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/silvybrand.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/silvybrand.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/silvybrand.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/silvybrand.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4193"}],"version-history":[{"count":0,"href":"https:\/\/silvybrand.com\/index.php?rest_route=\/wp\/v2\/posts\/4193\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/silvybrand.com\/index.php?rest_route=\/wp\/v2\/media\/4194"}],"wp:attachment":[{"href":"https:\/\/silvybrand.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4193"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/silvybrand.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4193"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/silvybrand.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4193"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}